You are here:  » Studies 

Studies

Intensive research in medicine is necessary to be able to offer better treatment possibilities to cure autoinflammatory diseases and to offer relief. Before any medical know-how can be included in standard diagnostics or therapy it has to be thoroughly examined in clinical trials. Hereby and as a rule, new treatment methods, or drugs respectively, are examined as to their efficacy and compatibility in connection with various allergological diseases.

We are looking for people with a permanent interest for our clinical trials. Patients interested in participating in clinical studies can get in touch with Ms Hesna Gözlükaya,

Tel.: 030 450 618 296,E-Mail: hesna.goezluekaya@charite.de

Our latest studies:

Schnitzler-Syndrom (monocentric IIT)

Monday, 16. April 2018  |  Category: Studies   

A new study for Schnitzler syndrome

Schnitzler Syndrome (multi-centre IIT)

Monday, 22. September 2014  |  Category: Studies   

01/2018: The study was successfully completed.

Adult-onset Still's disease (multicenter IIT)

Wednesday, 30. November 2011  |  Category: Studies   

A multicentre, placebo-controlled Phase II Study with Canakinumab to treat Adult-onset Still’s disease 12 patients were included in 2013.

Breaking News:

Schnitzler-Syndrom (monocentric IIT)

16.04.2018  |  Cat: Studies

A new study for Schnitzler syndrome

4th Autoinflammation Masterclass 28. - 29.04.2016 in Berlin

11.04.2016  |  Cat: News

Dear Colleagues, It is a pleasure for us to cordially welcome you to the beautiful city of Berlin...

8th International Congress of Familial Mediterranean Fever and Systemic Autoinflammatory Diseases

24.03.2015  |  Cat: News

30. September - 03. October 2015 in Dresden (Germany)